JPS5892619A - インタ−フエロンを安定に配合した組成物 - Google Patents
インタ−フエロンを安定に配合した組成物Info
- Publication number
- JPS5892619A JPS5892619A JP19125081A JP19125081A JPS5892619A JP S5892619 A JPS5892619 A JP S5892619A JP 19125081 A JP19125081 A JP 19125081A JP 19125081 A JP19125081 A JP 19125081A JP S5892619 A JPS5892619 A JP S5892619A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- items
- interferon
- administration
- sugar alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010050904 Interferons Proteins 0.000 title claims abstract description 49
- 102000014150 Interferons Human genes 0.000 title claims abstract description 47
- 229940079322 interferon Drugs 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 10
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000003381 stabilizer Substances 0.000 claims abstract description 6
- 239000004386 Erythritol Substances 0.000 claims abstract description 5
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 5
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 5
- 235000019414 erythritol Nutrition 0.000 claims abstract description 5
- 229940009714 erythritol Drugs 0.000 claims abstract description 5
- 235000011187 glycerol Nutrition 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims abstract description 3
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 3
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 3
- 150000007524 organic acids Chemical class 0.000 claims abstract description 3
- 235000000346 sugar Nutrition 0.000 claims abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 3
- 239000011593 sulfur Substances 0.000 claims abstract description 3
- 230000002378 acidificating effect Effects 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 238000007915 intraurethral administration Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 210000000664 rectum Anatomy 0.000 abstract 1
- 210000003708 urethra Anatomy 0.000 abstract 1
- 210000001215 vagina Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 239000000499 gel Substances 0.000 description 12
- 235000015927 pasta Nutrition 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- REYLLNRLWCBKCM-YFKPBYRVSA-N (2s)-2-acetamido-4-sulfanylbutanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCS REYLLNRLWCBKCM-YFKPBYRVSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-KKQCNMDGSA-N D-gulonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-KKQCNMDGSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- IAJILQKETJEXLJ-LECHCGJUSA-N iduronic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-LECHCGJUSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000008362 succinate buffer Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- YODZTKMDCQEPHD-UHFFFAOYSA-N thiodiglycol Chemical compound OCCSCCO YODZTKMDCQEPHD-UHFFFAOYSA-N 0.000 description 1
- 229950006389 thiodiglycol Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19125081A JPS5892619A (ja) | 1981-11-28 | 1981-11-28 | インタ−フエロンを安定に配合した組成物 |
| EP82306319A EP0080879B1 (en) | 1981-11-28 | 1982-11-26 | Pharmaceutical composition containing interferon in stable state |
| DE8282306319T DE3273597D1 (en) | 1981-11-28 | 1982-11-26 | Pharmaceutical composition containing interferon in stable state |
| US06/568,033 US4675184A (en) | 1981-11-28 | 1984-01-04 | Pharmaceutical composition containing interferon in stable state |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19125081A JPS5892619A (ja) | 1981-11-28 | 1981-11-28 | インタ−フエロンを安定に配合した組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5892619A true JPS5892619A (ja) | 1983-06-02 |
| JPS6260370B2 JPS6260370B2 (cg-RX-API-DMAC7.html) | 1987-12-16 |
Family
ID=16271398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19125081A Granted JPS5892619A (ja) | 1981-11-28 | 1981-11-28 | インタ−フエロンを安定に配合した組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5892619A (cg-RX-API-DMAC7.html) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6034919A (ja) * | 1983-08-04 | 1985-02-22 | Green Cross Corp:The | ガンマ・インタ−フェロン組成物 |
| JPS6048933A (ja) * | 1983-08-29 | 1985-03-16 | Green Cross Corp:The | ガンマ−・インタ−フェロン組成物 |
| JPS6267032A (ja) * | 1985-09-13 | 1987-03-26 | シタス コ−ポレイシヨン | 組換ヒトβ―インターフェロンを含有する医薬組成物及びその製造方法 |
| JPS63146827A (ja) * | 1986-07-18 | 1988-06-18 | Chugai Pharmaceut Co Ltd | 安定な顆粒球コロニ−刺激因子含有製剤 |
| JPH07119501B2 (ja) * | 1988-12-28 | 1995-12-20 | 敏郎 鈴木 | コンクリート支柱材 |
| JPWO2003072123A1 (ja) * | 2002-02-28 | 2005-06-16 | ニプロ株式会社 | 安定化されたアルブミン製剤 |
| JP2009091363A (ja) * | 2008-11-21 | 2009-04-30 | Asahi Kasei Pharma Kk | Ｐｔｈの安定化水溶液注射剤 |
| JP2013172719A (ja) * | 1999-04-16 | 2013-09-05 | Sanei Gen Ffi Inc | スクラロース含有組成物及び該組成物を含む可食性製品 |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04100882U (ja) * | 1991-01-31 | 1992-09-01 | 凸版印刷株式会社 | 芳香性印刷物 |
| JPH04115687U (ja) * | 1991-03-27 | 1992-10-14 | 大日本印刷株式会社 | メールフオーム |
| US6418556B1 (en) | 1993-09-09 | 2002-07-09 | United Video Properties, Inc. | Electronic television program guide schedule system and method |
| US6002394A (en) | 1995-10-02 | 1999-12-14 | Starsight Telecast, Inc. | Systems and methods for linking television viewers with advertisers and broadcasters |
| US8850477B2 (en) | 1995-10-02 | 2014-09-30 | Starsight Telecast, Inc. | Systems and methods for linking television viewers with advertisers and broadcasters |
| US5940073A (en) | 1996-05-03 | 1999-08-17 | Starsight Telecast Inc. | Method and system for displaying other information in a TV program guide |
| DE69812701T2 (de) | 1997-07-21 | 2004-02-05 | E Guide, Inc., Pasadena | Verfahren zum navigieren in einem fernsehprogrammführer mit werbung |
| US6604240B2 (en) | 1997-10-06 | 2003-08-05 | United Video Properties, Inc. | Interactive television program guide system with operator showcase |
| JP3694237B2 (ja) | 1997-12-01 | 2005-09-14 | スターサイト テレキャスト インコーポレイテッド | ポップアップに広告メッセージを伴う電子番組ガイドシステム |
| US20020095676A1 (en) | 1998-05-15 | 2002-07-18 | Robert A. Knee | Interactive television program guide system for determining user values for demographic categories |
| CN1867068A (zh) | 1998-07-14 | 2006-11-22 | 联合视频制品公司 | 交互式电视节目导视系统及其方法 |
| WO2001001689A1 (en) | 1999-06-29 | 2001-01-04 | United Video Properties, Inc. | Method and system for a video-on-demand-related interactive display within an interactive television application |
| US20010047298A1 (en) | 2000-03-31 | 2001-11-29 | United Video Properties,Inc. | System and method for metadata-linked advertisements |
| JP2004511937A (ja) | 2000-10-11 | 2004-04-15 | ユナイテッド ビデオ プロパティーズ， インコーポレイテッド | オン−デマンドメディア送達システムのサーバにおけるデータの格納を提供するシステムおよび方法 |
| US7493646B2 (en) | 2003-01-30 | 2009-02-17 | United Video Properties, Inc. | Interactive television systems with digital video recording and adjustable reminders |
| US7984468B2 (en) | 2003-11-06 | 2011-07-19 | United Video Properties, Inc. | Systems and methods for providing program suggestions in an interactive television program guide |
| US8387089B1 (en) | 2005-05-06 | 2013-02-26 | Rovi Guides, Inc. | Systems and methods for providing a scan |
| US8640166B1 (en) | 2005-05-06 | 2014-01-28 | Rovi Guides, Inc. | Systems and methods for content surfing |
| US7788266B2 (en) | 2005-08-26 | 2010-08-31 | Veveo, Inc. | Method and system for processing ambiguous, multi-term search queries |
| US9113107B2 (en) | 2005-11-08 | 2015-08-18 | Rovi Guides, Inc. | Interactive advertising and program promotion in an interactive television system |
| US8380726B2 (en) | 2006-03-06 | 2013-02-19 | Veveo, Inc. | Methods and systems for selecting and presenting content based on a comparison of preference signatures from multiple users |
| US7801888B2 (en) | 2007-03-09 | 2010-09-21 | Microsoft Corporation | Media content search results ranked by popularity |
| US9166714B2 (en) | 2009-09-11 | 2015-10-20 | Veveo, Inc. | Method of and system for presenting enriched video viewing analytics |
| US8805418B2 (en) | 2011-12-23 | 2014-08-12 | United Video Properties, Inc. | Methods and systems for performing actions based on location-based rules |
-
1981
- 1981-11-28 JP JP19125081A patent/JPS5892619A/ja active Granted
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6034919A (ja) * | 1983-08-04 | 1985-02-22 | Green Cross Corp:The | ガンマ・インタ−フェロン組成物 |
| JPS6048933A (ja) * | 1983-08-29 | 1985-03-16 | Green Cross Corp:The | ガンマ−・インタ−フェロン組成物 |
| JPS6267032A (ja) * | 1985-09-13 | 1987-03-26 | シタス コ−ポレイシヨン | 組換ヒトβ―インターフェロンを含有する医薬組成物及びその製造方法 |
| JPS63146827A (ja) * | 1986-07-18 | 1988-06-18 | Chugai Pharmaceut Co Ltd | 安定な顆粒球コロニ−刺激因子含有製剤 |
| JPH07119501B2 (ja) * | 1988-12-28 | 1995-12-20 | 敏郎 鈴木 | コンクリート支柱材 |
| JP2013172719A (ja) * | 1999-04-16 | 2013-09-05 | Sanei Gen Ffi Inc | スクラロース含有組成物及び該組成物を含む可食性製品 |
| JPWO2003072123A1 (ja) * | 2002-02-28 | 2005-06-16 | ニプロ株式会社 | 安定化されたアルブミン製剤 |
| JP2009091363A (ja) * | 2008-11-21 | 2009-04-30 | Asahi Kasei Pharma Kk | Ｐｔｈの安定化水溶液注射剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6260370B2 (cg-RX-API-DMAC7.html) | 1987-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5892619A (ja) | インタ−フエロンを安定に配合した組成物 | |
| US4675184A (en) | Pharmaceutical composition containing interferon in stable state | |
| US5236707A (en) | Stabilization of human interferon | |
| DE3723781C2 (de) | Verwendung von Polyoxyäthylensorbitanestern einer aliphatischen Säure zur Stabilisierung von G-CSF (Granulocyten-Koloniestimulierender-Faktor) | |
| CA1254832A (en) | Interferon administration vehicles | |
| JPH07101856A (ja) | 口腔乾燥症状軽減の為の固形調剤形態製造物 | |
| JPS5910598A (ja) | 安定なインタ−フエロンβ組成物およびインタ−フエロンβの安定化方法 | |
| JPH04502017A (ja) | 小ペプチド類の安定化水系調剤 | |
| WO1999009968A1 (en) | Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption | |
| KR100589878B1 (ko) | 사람 성장 호르몬을 함유한 수성 의약 조성물 | |
| JPS62209024A (ja) | α−インタ−フエロンの安定化に適した処方物 | |
| JP4053586B2 (ja) | ガンマインターフェロンの安定液体組成物 | |
| DD289470A5 (de) | Verfahren zur herstellung eines arzneimittels mit einem gehalt an gamma-interferon | |
| JPS59181224A (ja) | 安定なインタ−フエロン製剤の製法 | |
| DE69426844T2 (de) | Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung | |
| CN103379918A (zh) | 口腔组合物及其制备和使用方法 | |
| JPS5892620A (ja) | インタ−フエロン安定配合組成物 | |
| CN103830180A (zh) | 一种盐酸溶菌酶口腔喷剂及其制备方法 | |
| JPS5892622A (ja) | インタ−フエロン安定配合製剤 | |
| WO1996031230A1 (en) | Medicinal composition for curing thrombocytopenia | |
| JPS61186307A (ja) | 口腔用組成物 | |
| JPS58167520A (ja) | インタ−フエロン安定配合製剤 | |
| JPS5892621A (ja) | インタ−フエロンを安定に配合した製剤 | |
| RU2184564C2 (ru) | Лекарственный гель | |
| JPS59181223A (ja) | インタ−フエロンの安定化法 |